Results of AbbVie’s Rinvoq in atopic dermatitis position it to rival Regeneron’s Dupixent

Rinvoq reportedly met all secondary endpoints in the study as well, especially in terms of reducing itch associated with atopic dermatitis. Credit: Shutterstock.



  • Rinvoq